The three-way interactions between the hypothalamic-pituitary-adrenal and gonadal axes and the immune system.

The stress system is controlled by brain nuclei at the hypothalamus and brainstem. These nuclei interact with each other and control the HPA axis and sympathetic nervous systems, respectively. Major inputs to the stress system arise from the cerebral cortex and subcortical systems, the sensory organs and nerves, and the endocrine and immune systems. The major peripheral effectors of the stress system are glucocorticoids and the catecholamines. Pathological hypoactivity of the stress system has been associated with atypical depression, the chronic fatigue/fibromyalgia syndromes and autoimmune inflammatory disease; hyperactivity with melancholic depression and anxiety disorders. The stress system responds in a quantitatively and qualitatively specific fashion to different stressors. A major role of the HPA axis is to restrain the immune system and prevent tissue damage. Reciprocal interactions between the HPA axis and immune system constitutes a new endocrine feedback loop that has given rise to the field of neuroendocrine immunology. Gonadal axis hormones directly, and indirectly via the HPA axis, alter the tone of the immune system and the quality and quantity of the inflammatory responses. Effects of the HPA axis on the gonadal axis are consistent with conservation and redirection of valuable resources towards homeostasis during times of stress. These complex interactions between the HPA axis, immune and the gonadal systems may prove to be fundamental in the genesis and perpetuation of autoimmune disease.

[1]  M. Dallman,et al.  Corticosterone acts on the brain to inhibit adrenalectomy-induced adrenocorticotropin secretion. , 1988, Endocrinology.

[2]  M. Merino,et al.  Presence of immunoreactive corticotropin releasing hormone in thyroid lesions. , 1994, The American journal of pathology.

[3]  Schürmeyer Th On the relationship between ACTH and cortisol secretion. , 1987 .

[4]  S. Al-Damluji,et al.  Adrenergic mechanisms in the control of corticotrophin secretion. , 1988, The Journal of endocrinology.

[5]  G. Chrousos,et al.  Increased plasma concentrations, hypothalamic content, and in vitro release of arginine vasopressin in inflammatory disease-prone, hypothalamic corticotropin-releasing hormone-deficient Lewis rats. , 1992, Endocrinology.

[6]  E. D. de Kloet,et al.  The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. , 1995, The Journal of endocrinology.

[7]  D. Orth Corticotropin-releasing hormone in humans. , 1992, Endocrine reviews.

[8]  C. Tsigos,et al.  Physiology of the hypothalamic-pituitary-adrenal axis in health and dysregulation in psychiatric and autoimmune disorders. , 1994, Endocrinology and metabolism clinics of North America.

[9]  G. Chrousos,et al.  The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.

[10]  N. Barden,et al.  Estrogen-induced decrease of glucocorticoid receptor messenger ribonucleic acid concentration in rat anterior pituitary gland. , 1987, Molecular endocrinology.

[11]  G. Kingsley,et al.  Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. , 1992, Arthritis and rheumatism.

[12]  G. Chrousos,et al.  The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. , 1992, JAMA.

[13]  D. Boumpas,et al.  Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates , 1993, Annals of Internal Medicine.

[14]  A. Baum,et al.  Sex differences in sensitivity of the hypothalamic-pituitary-adrenal axis. , 1993, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[15]  G. Chrousos,et al.  Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. , 1991, Science.

[16]  M. Ferin,et al.  The hypothalamic control of the menstrual cycle and the role of endogenous opioid peptides. , 1984, Recent progress in hormone research.

[17]  D. Torpy,et al.  Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man. , 1993, The Journal of clinical endocrinology and metabolism.

[18]  C. Nemeroff,et al.  Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. , 1988, Archives of general psychiatry.

[19]  B. Robinson,et al.  Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[20]  F. Rose The Control of the hypothalamo-pituitary-adrenocortical axis , 1989 .

[21]  H. Imura,et al.  Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats. , 1985, Endocrinology.

[22]  D. Jezova,et al.  Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. , 1991, Neuroendocrinology.

[23]  M. Whitnall Stress selectively activates the vasopressin-containing subset of corticotropin-releasing hormone neurons. , 1989, Neuroendocrinology.

[24]  E. van Cauter,et al.  Effects of "jet lag" on hormonal patterns. I. Procedures, variations in total plasma proteins, and disruption of adrenocorticotropin-cortisol periodicity. , 1981, The Journal of clinical endocrinology and metabolism.

[25]  L. Swanson,et al.  The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat , 1982, Brain Research Reviews.

[26]  A. Grossman,et al.  Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in man. , 1987, Neuroendocrinology.

[27]  R. Handa,et al.  Gonadal Steroid Hormone Receptors and Sex Differences in the Hypothalamo-Pituitary-Adrenal Axis , 1994, Hormones and Behavior.

[28]  W. Vale,et al.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin , 1981 .

[29]  T. Suda,et al.  Inhibitory effect of adrenocorticotropin on corticotropin- releasing factor release from rat hypothalamus in vitro. , 1986, Endocrinology.

[30]  S. Mccann,et al.  Ultrashort-loop positive feedback of corticotropin (ACTH)-releasing factor to enhance ACTH release in stress. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Dallman,et al.  Chronic streptozotocin diabetes in rats facilitates the acute stress response without altering pituitary or adrenal responsiveness to secretagogues. , 1991, Endocrinology.

[32]  F. Antoni Vasopressinergic Control of Pituitary Adrenocorticotropin Secretion Comes of Age , 1993, Frontiers in Neuroendocrinology.

[33]  J. Doppman,et al.  Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. , 1991, The New England journal of medicine.

[34]  A. Iranmanesh,et al.  Intensive venous sampling paradigms disclose high frequency adrenocorticotropin release episodes in normal men. , 1990, The Journal of clinical endocrinology and metabolism.

[35]  W. Vale,et al.  Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. , 1984, The Journal of clinical investigation.

[36]  A. F. Muller,et al.  RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Grossman,et al.  Corticotropin-releasing hormone in health and disease: an update. , 1992, Acta endocrinologica.

[38]  B. Allolio,et al.  The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. , 1993, The Journal of clinical endocrinology and metabolism.

[39]  Guy Hoffman,et al.  Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. , 1994, The Journal of clinical investigation.

[40]  R. Ekman,et al.  Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics , 1991, Acta psychiatrica Scandinavica.

[41]  H SELYE,et al.  [General adaptation syndrome and diseases of adaptation]. , 1946, L'union medicale du Canada.

[42]  J W Funder,et al.  Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia. , 1989, Neuroendocrinology.

[43]  G. Chrousos,et al.  Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. , 1994, Endocrine reviews.

[44]  I. Clarke,et al.  Glucocorticoids regulate ovine hypophysial portal levels of corticotropin-releasing factor and arginine vasopressin in a stress-specific manner. , 1989, Endocrinology.

[45]  G. Chrousos,et al.  Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. , 1995, The Journal of clinical investigation.

[46]  G. Chrousos,et al.  Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. , 1992, The Journal of clinical investigation.

[47]  G. Chrousos,et al.  Immune corticotropin-releasing hormone is present in the eyes of and promotes experimental autoimmune uveoretinitis in rodents. , 1995, Endocrinology.

[48]  J. I. Kitay,et al.  Adrenocortical function in the hamster. Sex differences and effects of gonadal hormones. , 1970, Endocrinology.

[49]  S. George,et al.  Gonadal regulation of corticotropin-releasing factor immunoreactivity in hypothalamus , 1988, Brain Research Bulletin.

[50]  D. Blatter,et al.  Sex hormonal effects on the severity of streptococcal cell wall-induced polyarthritis in the rat. , 1983, Arthritis and rheumatism.

[51]  W. Pardridge,et al.  Receptor-mediated peptide transport through the blood-brain barrier. , 1986, Endocrine reviews.

[52]  J. Amsterdam,et al.  Assessment of adrenal gland volume by computed tomography in depressed patients and healthy volunteers: A pilot study , 1987, Psychiatry Research.

[53]  M. Dallman,et al.  Corticosteroid inhibition of ACTH secretion. , 1984, Endocrine reviews.

[54]  A. Grossman,et al.  Differential effects of opiate peptides and alkaloids on anterior pituitary hormone secretion. , 1983, Neuroendocrinology.

[55]  P. Plotsky,et al.  Pathways to the Secretion of Adrenocorticotropin: A View from the Portal * , 1991, Journal of neuroendocrinology.

[56]  R. Zoeller,et al.  Corticotropin releasing hormone mRNA is elevated on the afternoon of proestrus in the parvocellular paraventricular nuclei of the female rat. , 1990, Brain research. Molecular brain research.

[57]  F. Goodwin,et al.  Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) , 1988, The New England journal of medicine.

[58]  I. Clarke,et al.  Corticotropin-release inhibitory factor Evidence for dual stimulatory and inhibitory hypothalamic regulation over adrenocorticotropin secretion and biosynthesis , 1994, Trends in Endocrinology & Metabolism.

[59]  S. Pillemer,et al.  Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. , 1994, Arthritis and rheumatism.

[60]  B. McEwen,et al.  Adrenal steroid receptors and actions in the nervous system. , 1986, Physiological reviews.

[61]  R L Wilder,et al.  Neuroendocrine-immune system interactions and autoimmunity. , 1995, Annual review of immunology.

[62]  B. B. Turner,et al.  Sex differences in the binding of Type I and type II corticosteroid receptors in rat hippocampus , 1992, Brain Research.

[63]  W. Cowan,et al.  Direct hypothalamo-autonomic connections , 1976, Brain Research.

[64]  R. Williams,et al.  Williams Textbook of endocrinology , 1985 .

[65]  A. Lewy,et al.  Circadian rhythm abnormalities in totally blind people: incidence and clinical significance. , 1992, The Journal of clinical endocrinology and metabolism.

[66]  G. Chrousos,et al.  The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing syndrome. , 1993, The Journal of clinical endocrinology and metabolism.

[67]  G. Chrousos,et al.  Glucocorticoid and/or glucocorticoid antagonist effects in inflammatory disease-susceptible Lewis rats and inflammatory disease-resistant Fischer rats. , 1995, Endocrinology.

[68]  K. Catt,et al.  Magnocellular axons in passage through the median eminence release vasopressin , 1986, Nature.

[69]  N. Ekhator,et al.  Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans. , 1992, The Journal of clinical endocrinology and metabolism.

[70]  G. Chrousos,et al.  Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications. , 1988, The Journal of clinical investigation.

[71]  C. Oliver,et al.  Insulin-induced hypoglycemia stimulates corticotropin-releasing factor and arginine vasopressin secretion into hypophysial portal blood of conscious, unrestrained rams. , 1990, The Journal of clinical investigation.

[72]  N. Holbrook,et al.  Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. , 1984, Endocrine reviews.

[73]  G. Kroemer,et al.  Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. , 1993, Endocrine reviews.

[74]  S. Makino,et al.  Corticotropin-releasing hormone and pituitary-adrenocortical responses in chronically stressed rats , 1988, Regulatory Peptides.

[75]  K. Federlin,et al.  Adrenal secretion of cortisol in patients with rheumatoid arthritis. , 1990, The Journal of rheumatology.

[76]  G. Chrousos,et al.  Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone. , 1992, Neuroendocrinology.

[77]  G. Chrousos,et al.  Exercise-induced activation of the hypothalamic-pituitary-adrenal axis: marked differences in the sensitivity to glucocorticoid suppression. , 1994, The Journal of clinical endocrinology and metabolism.

[78]  A. Steinberg,et al.  Modulation of the expression of murine lupus by gonadotropin-releasing hormone analogs. , 1994, Endocrinology.

[79]  F. Bloom,et al.  Corticotropin-releasing factor and behavior. , 1985, Federation proceedings.

[80]  K. Catt,et al.  Mechanisms of action of corticotropin-releasing factor and other regulators of corticotropin release in rat pituitary cells. , 1983, The Journal of biological chemistry.

[81]  S. Foote,et al.  Corticotropin-releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus coeruleus neurons in unanesthetized rats , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[82]  B. Canny,et al.  Distinct classes of corticotropes mediate corticotropin-releasing hormone- and arginine vasopressin-stimulated adrenocorticotropin release. , 1991, Endocrinology.

[83]  R. Post,et al.  Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. , 1984, The American journal of psychiatry.

[84]  E. Remmers,et al.  Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. , 1993, Journal of immunology.

[85]  H. Besedovsky,et al.  Network of immune-neuroendocrine interactions. , 1977, Clinical and experimental immunology.

[86]  B. McEwen,et al.  Adaptation of the hypothalamic-pituitary-adrenal axis to chronic ethanol stress. , 1990, Neuroendocrinology.

[87]  S. Lightman,et al.  Stress and the hypothalamo-pituitary-adrenal axis: acute, chronic and immunological activation. , 1992, The Journal of endocrinology.

[88]  B. B. Turner,et al.  Sex difference in glucocorticoid binding in rat pituitary is estrogen dependent. , 1990, Life sciences.

[89]  J. Funder,et al.  Effect of AVP on susceptibility of ovine pituitary cells to a cytotoxic analogue of CRF. , 1991, The American journal of physiology.

[90]  S. Cummings,et al.  Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[91]  C. Craddock Corticosteroid-induced lymphopenia, immunosuppression, and body defense. , 1978, Annals of internal medicine.

[92]  G. Chrousos,et al.  Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion. , 1984, The Journal of clinical endocrinology and metabolism.

[93]  G. Chrousos,et al.  Ovine corticotropin-releasing factor administration in normal men. Pituitary and adrenal responses in the morning and evening. , 1985, Hormone research.

[94]  J. Seckl,et al.  Atriopeptin: an endogenous corticotropin-release inhibiting hormone. , 1992, Endocrinology.

[95]  B. Carroll,et al.  A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. , 1981, Archives of general psychiatry.

[96]  B Stein,et al.  Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta , 1995, Molecular and cellular biology.

[97]  E. R. Kloet,et al.  Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. , 1985, Endocrinology.

[98]  K. Krishnan,et al.  Pituitary size in depression. , 1991, The Journal of clinical endocrinology and metabolism.

[99]  E. Redei,et al.  Corticotropin release-inhibiting factor is preprothyrotropin-releasing hormone-(178-199). , 1995, Endocrinology.

[100]  C. Edwards,et al.  Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor. , 1988, Lancet.

[101]  D. Pfaff,et al.  Absence of oestradiol concentration in cell nuclei of LHRH-immunoreactive neurones , 1983, Nature.

[102]  K. Catt,et al.  Phorbol 12-myristate 13-acetate and vasopressin potentiate the effect of corticotropin-releasing factor on cyclic AMP production in rat anterior pituitary cells. Mechanisms of action. , 1987, The Journal of biological chemistry.